[HTML][HTML] Multiple criteria decision analysis (MCDA) for evaluating new medicines in health technology assessment and beyond: the advance value framework
Escalating drug prices have catalysed the generation of numerous “value frameworks” with
the aim of informing payers, clinicians and patients on the assessment and appraisal …
the aim of informing payers, clinicians and patients on the assessment and appraisal …
Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework
A Angelis, P Kanavos - Social Science & Medicine, 2017 - ideas.repec.org
Escalating drug prices have catalysed the generation of numerous “value frameworks” with
the aim of informing payers, clinicians and patients on the assessment and appraisal …
the aim of informing payers, clinicians and patients on the assessment and appraisal …
Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework.
A Angelis, P Kanavos - Social Science & Medicine (1982), 2017 - europepmc.org
Escalating drug prices have catalysed the generation of numerous" value frameworks" with
the aim of informing payers, clinicians and patients on the assessment and appraisal …
the aim of informing payers, clinicians and patients on the assessment and appraisal …
[PDF][PDF] Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework
A Angelis, P Kanavos - Social Science & Medicine, 2017 - pink.citeline.com
abstract Escalating drug prices have catalysed the generation of numerous “value
frameworks” with the aim of informing payers, clinicians and patients on the assessment and …
frameworks” with the aim of informing payers, clinicians and patients on the assessment and …
[PDF][PDF] Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework
A Angelis, P Kanavos - Social Science & Medicine, 2017 - researchgate.net
abstract Escalating drug prices have catalysed the generation of numerous “value
frameworks” with the aim of informing payers, clinicians and patients on the assessment and …
frameworks” with the aim of informing payers, clinicians and patients on the assessment and …
[PDF][PDF] Multiple Criteria Decision Analysis (MCDA) for Evaluating New Medicines in Health Technology Assessment and Beyond: The Advance Value Framework
A Angelis - 2017 - cyberleninka.org
Escalating drug prices have catalysed the generation of numerous “value frameworks” with
the aim of informing payers, clinicians and patients on the assessment process of new …
the aim of informing payers, clinicians and patients on the assessment process of new …
[PDF][PDF] Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: the Advance Value Framework
A Angelis, P Kanavos - 2017 - core.ac.uk
Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology
Assessment and beyond: the Advance Page 1 Aris Angelis and Panos Kanavos Multiple Criteria …
Assessment and beyond: the Advance Page 1 Aris Angelis and Panos Kanavos Multiple Criteria …
Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework
A Angelis, P Kanavos - Social science & medicine (1982), 2017 - pubmed.ncbi.nlm.nih.gov
Escalating drug prices have catalysed the generation of numerous" value frameworks" with
the aim of informing payers, clinicians and patients on the assessment and appraisal …
the aim of informing payers, clinicians and patients on the assessment and appraisal …
Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework
A Angelis, P Kanavos - Social Science & Medicine, 2017 - econpapers.repec.org
Escalating drug prices have catalysed the generation of numerous “value frameworks” with
the aim of informing payers, clinicians and patients on the assessment and appraisal …
the aim of informing payers, clinicians and patients on the assessment and appraisal …
Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: the Advance Value Framework
A Angelis, P Kanavos - Social Science & Medicine, 2017 - eprints.lse.ac.uk
Escalating drug prices have catalysed the generation of numerous “value frameworks” with
the aim of informing payers, clinicians and patients on the assessment process of new …
the aim of informing payers, clinicians and patients on the assessment process of new …